These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35723968)

  • 1. Ancestrally Reconstructed von Willebrand Factor Reveals Evidence for Trench Warfare Coevolution between Opossums and Pit Vipers.
    Drabeck DH; Rucavado A; Hingst-Zaher E; Dean A; Jansa SA
    Mol Biol Evol; 2022 Jul; 39(7):. PubMed ID: 35723968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of South American opossums to vWF-binding venom C-type lectins.
    Drabeck DH; Rucavado A; Hingst-Zaher E; Cruz YP; Dean AM; Jansa SA
    Toxicon; 2020 Apr; 178():92-99. PubMed ID: 32135198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive evolution of the venom-targeted vWF protein in opossums that eat pitvipers.
    Jansa SA; Voss RS
    PLoS One; 2011; 6(6):e20997. PubMed ID: 21731638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snake-venom resistance as a mammalian trophic adaptation: lessons from didelphid marsupials.
    Voss RS; Jansa SA
    Biol Rev Camb Philos Soc; 2012 Nov; 87(4):822-37. PubMed ID: 22404916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of snake venom toxins interacting with human von Willebrand factor.
    Matsui T; Hamako J
    Toxicon; 2005 Jun; 45(8):1075-87. PubMed ID: 15922776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venomous snakes of Costa Rica: biological and medical implications of their venom proteomic profiles analyzed through the strategy of snake venomics.
    Lomonte B; Fernández J; Sanz L; Angulo Y; Sasa M; Gutiérrez JM; Calvete JJ
    J Proteomics; 2014 Jun; 105():323-39. PubMed ID: 24576642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of von Willebrand factor and botrocetin in the thrombocytopenia induced by Bothrops jararaca snake venom.
    Thomazini CM; Sachetto ATA; de Albuquerque CZ; de Moura Mattaraia VG; de Oliveira AK; Serrano SMT; Lebrun I; Barbaro KC; Santoro ML
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009715. PubMed ID: 34478462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opossums (Mammalia: Didelphidae) in the diets of Neotropical pitvipers (Serpentes: Crotalinae): evidence for alternative coevolutionary outcomes?
    Voss RS
    Toxicon; 2013 May; 66():1-6. PubMed ID: 23402839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the cysteine-rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation.
    Serrano SMT; Wang D; Shannon JD; Pinto AFM; Polanowska-Grabowska RK; Fox JW
    FEBS J; 2007 Jul; 274(14):3611-3621. PubMed ID: 17578514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bitiscetin-3, a Novel C-Type Lectin-like Protein Cloned from the Venom Gland of the Viper
    Nashimoto Y; Matsushita F; Dijkstra JM; Nakamura Y; Akiyama H; Hamako J; Morita T; Araki S; Matsui T
    Toxins (Basel); 2022 Mar; 14(4):. PubMed ID: 35448845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical applications of snake venom toxins in haemostasis.
    Marsh N; Williams V
    Toxicon; 2005 Jun; 45(8):1171-81. PubMed ID: 15922782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Analysis of Alpha-1 Orthosteric-Site Binding by a Clade of Central American Pit Vipers (Genera
    Jones L; Waite C; Neri-Castro E; Fry BG
    Toxins (Basel); 2023 Aug; 15(8):. PubMed ID: 37624244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Danger in the Canopy. Comparative Proteomics and Bioactivities of the Venoms of the South American Palm Pit Viper
    Sanz L; Quesada-Bernat S; Pérez A; De Morais-Zani K; SantˈAnna SS; Hatakeyama DM; Tasima LJ; De Souza MB; Kayano AM; Zavaleta A; Salas M; Soares AM; Calderón LA; Tanaka-Azevedo AM; Lomonte B; Calvete JJ; Caldeira CAS
    J Proteome Res; 2020 Aug; 19(8):3518-3532. PubMed ID: 32686412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding Biological Roles of Venoms Among the Caenophidia: The Importance of Rear-Fanged Snakes.
    Mackessy SP; Saviola AJ
    Integr Comp Biol; 2016 Nov; 56(5):1004-1021. PubMed ID: 27639275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of bitiscetin, a novel von Willebrand factor modulator protein from Bitis arietans snake venom.
    Hamako J; Matsui T; Suzuki M; Ito M; Makita K; Fujimura Y; Ozeki Y; Titani K
    Biochem Biophys Res Commun; 1996 Sep; 226(1):273-9. PubMed ID: 8806626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.
    Rabinowitz I; Tuley EA; Mancuso DJ; Randi AM; Firkin BG; Howard MA; Sadler JE
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9846-9. PubMed ID: 1409710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Antivenom and Small-Molecule Inhibition of Novel Coagulotoxic Variations in
    Jones L; Youngman NJ; Neri-Castro E; Guadarrama-Martínez A; Lewin MR; Carter R; Frank N; Fry BG
    Toxins (Basel); 2022 Jul; 14(8):. PubMed ID: 35893753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding site on human von Willebrand factor of bitiscetin, a snake venom-derived platelet aggregation inducer.
    Matsui T; Hamako J; Matsushita T; Nakayama T; Fujimura Y; Titani K
    Biochemistry; 2002 Jun; 41(25):7939-46. PubMed ID: 12069583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Profile Analysis of Two Australian Snake Venoms by One- Dimensional Gel Electrophoresis and MS/MS Experiments.
    Georgieva D; Hildebrand D; Simas R; Coronado MA; Kwiatkowski M; Schlüter H; Arni R; Spencer P; Betzel C
    Curr Med Chem; 2017; 24(17):1892-1908. PubMed ID: 28571558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro assessment and phase I randomized clinical trial of anfibatide a snake venom derived anti-thrombotic agent targeting human platelet GPIbα.
    Li BX; Dai X; Xu XR; Adili R; Neves MAD; Lei X; Shen C; Zhu G; Wang Y; Zhou H; Hou Y; Ni T; Pasman Y; Yang Z; Qian F; Zhao Y; Gao Y; Liu J; Teng M; Marshall AH; Cerenzia EG; Li ML; Ni H
    Sci Rep; 2021 Jun; 11(1):11663. PubMed ID: 34083615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.